About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 176 record(s)
Req # A-2022-000742
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108585-282, Membership to the Clinical Laboratory Standards Institute in 2023-24.Organization: Health Canada
September 2022
Req # A-2022-000747
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108545-748, Upcoming Publication of Proposed and Final Post-Market Decisions for Pesticides.Organization: Health Canada
September 2022
Req # A-2022-000257
The number of rapid tests distributed to government employees by department for each month and for each product type since September 2020. The number of rapid tests distributed to the private sector by organization during the same timeframe.Organization: Health Canada
September 2022
Req # A-2022-000630
The driving factors for management in the Health Product and Food Branch (HPFB) and the governing hierarchy, the criteria for achieving the performance pay for all HPFB executives, by position. Records for the following fiscal years. (2019-2020, 2020-2021. 2021-2022, 2022-2023).Organization: Health Canada
September 2022
Req # A-2021-000558
As part of a study on the production of organic and sustainable cosmetics in Canada, a listing of all Canadian cosmetics manufacturers who are registered in accordance with Health Canada's "Notification of Cosmetics," as per section 30 of the Cosmetic Regulations.Organization: Health Canada
August 2022
Req # A-2022-000328
Number of licences issued for cannabis cultivation, by year, for each of the years 2016 to 2021, between August 24, 2016 and June 11, 2022 in Quebec and in each of the other Canadian provinces. The same figures for the beginning of 2022 if available to June 11, 2022. Number of cannabis cultivation licences revoked, by year, for each of the years 2016 to 2021, between August 24, 2016 and June 11, 2022 in Quebec and in each of the other Canadian provinces. Number of inspections conducted for licences issued, by year, for each of the years 2016 to 2021, between August 24, 2016 and June 11, 2022 in Quebec and in each of the other Canadian provinces. The number of calls/notifications to Health Canada from police forces regarding cannabis cultivation permits between August 24, 2016 and June 11, 2022.Organization: Health Canada
August 2022
Req # A-2022-000483
Data and reports that were commissioned by Health Canada to understand Canadian perceptions regarding Cannabis use and specific product formats such as vapes. The reports should stem from 2018 to July 12, 2022.Organization: Health Canada
August 2022
Req # A-2022-000520
All safety data for the health effects of electric cars on our environment. Safety data for power charging stations for electric cars. All data for the effects of these charging stations. Data on the effects of lithium mining to make the batteries. All data on lithium safety for Canadians.Organization: Health Canada
August 2022
Req # A-2017-001468
Adverse Drug Reactions (ADRs) for PANTOPRAZOLE SODIUM. Report numbers: E2B_01380857, E2B_01387851, E2B_01393344, E2B_01393381, E2B_01393401, E2B_01393424, E2B_01393430, E2B_01397498, E2B_01399399, E2B_01399517, E2B_01399528, E2B_01399543, E2B_01399552, E2B_01401642, E2B_01401647, E2B_01401654, E2B_01403779, E2B_01403781, E2B_01403783, E2B_01403792, E2B_01403794, E2B_01405655, E2B_01405659, E2B_01405663, E2B_01407198, E2B_01407879, E2B_01412413, E2B_01412727, E2B_01415415, E2B_01416813.Organization: Health Canada
August 2022
Req # A-2021-002094
Adverse Drug Reactions (ADRs) for ALEMTUZUMAB, METOLAZONE, METFORMIN HYDROCHLORIDE. Report numbers: E2B_04943076, E2B_04768754, E2B_04812820, E2B_04715183, E2B_04674084, E2B_04771838.Organization: Health Canada
August 2022